2-carbazol-9-yl-3-(N-dibenzofuran-3-yl-4-phenylanilino)-4-isocyanobenzonitrile
C44H26N4O — CID 166027921
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-carbazol-9-yl-3-(N-dibenzofuran-3-yl-4-phenylanilino)-4-isocyanobenzonitrile
2-carbazol-9-yl-3-(N-dibenzofuran-3-yl-4-phenylanilino)-4-isocyanobenzonitrile (PubChem CID 166027921) has the molecular formula C44H26N4O and a molecular weight of 626.72 g/mol. Its IUPAC name is 2-carbazol-9-yl-3-(N-dibenzofuran-3-yl-4-phenylanilino)-4-isocyanobenzonitrile.
Molecular Properties
| Compound Name | 2-carbazol-9-yl-3-(N-dibenzofuran-3-yl-4-phenylanilino)-4-isocyanobenzonitrile |
|---|---|
| PubChem CID | 166027921 |
| Molecular Formula | C44H26N4O |
| Molecular Weight | 626.72 g/mol |
| Exact Mass | 626.21 |
| IUPAC Name | 2-carbazol-9-yl-3-(N-dibenzofuran-3-yl-4-phenylanilino)-4-isocyanobenzonitrile |
| SMILES | [C-]#[N+]c1ccc(C#N)c(-n2c3ccccc3c3ccccc32)c1N(c1ccc(-c2ccccc2)cc1)c1ccc2c(c1)oc1ccccc12 |
| InChI | InChI=1S/C44H26N4O/c1-46-38-26-21-31(28-45)43(48-39-16-8-5-13-34(39)35-14-6-9-17-40(35)48)44(38)47(32-22-19-30(20-23-32)29-11-3-2-4-12-29)33-24-25-37-36-15-7-10-18-41(36)49-42(37)27-33/h2-27H |
| InChIKey | YGVCYJWSRRUKPN-UHFFFAOYSA-N |
| XLogP | 12.24 |
| TPSA | 49.46 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 49 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 626.72 |
| LogP ≤ 5 | 12.24 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 166027921 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.